US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nuveen Minnesota Municipal Income Fund

12.08

-0.0042-0.03%

Volume:6.20K

Turnover:74.77K

Market Cap:74.75M

PE:11.84

High:12.08

Open:12.07

Low:12.05

Close:12.09

52wk High:12.50

52wk Low:11.07

Shares:6.19M

Float Shares:6.08M

Volume Ratio:0.96

T/O Rate:0.10%

Dividend:0.85

Dividend Rate:7.01%

EPS(TTM):1.02

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Blue Ocean Technologies Announces Executive Changes

Nuveen Minnesota Quality Municipal Income Fund Announces Monthly Distribution

Nuveen Minnesota Quality Municipal Income Fund Issues Monthly Distribution Notice

The National Museum of Singapore honours the nation's 60th anniversary with two new experiences to introduce Singapore's evolving story

Press Release: Evoke Pharma and QOL Medical Announce Expiration of Tender Offer

Nuveen Minnesota Quality Municipal Income Fund Announces Monthly Distribution

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

Cboe’s exit shows Australia needs Regulation NMS

Nuveen Minnesota Quality Municipal Income Fund Files Initial Beneficial Ownership Statement for VP and Treasurer Robert Tanner Page

FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder

Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Gilat Satellite announces AI transformation of its NMS integrated MCP

Gilat Becomes First to Market with AI-Powered Network Management System

Nuveen Minnesota Quality Municipal Income Fund Releases August 2025 Distribution Report

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship

Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NMS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMS\",,,,,undefined,":{"symbol":"NMS","market":"US","secType":"STK","nameCN":"Nuveen Minnesota Municipal Income Fund","latestPrice":12.0818,"timestamp":1770830892747,"preClose":12.086,"halted":0,"volume":6203,"delay":0,"changeRate":-0.00034750951514155796,"floatShares":6076299,"shares":6186608,"eps":1.02,"marketStatus":"Trading","change":-0.0042,"latestTime":"02-11 12:56:33 EST","open":12.0707,"high":12.0818,"low":12.045,"amount":74766.7966855,"amplitude":0.003045,"askPrice":12.09,"askSize":100,"bidPrice":12.04,"bidSize":100,"shortable":3,"etf":0,"ttmEps":1.02,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":12.086,"dividendRate":0.070072,"postHourTrading":{"tag":"盘后","latestPrice":12.086,"preClose":12.086,"latestTime":"16:10 EST","volume":32,"amount":385.602,"timestamp":1770757804910,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.96164},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMS\",,,,,undefined,":{"symbol":"NMS","floatShares":6076299,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.96164,"shares":6186608,"dividePrice":0.8466,"high":12.0818,"amplitude":0.003045,"preClose":12.086,"low":12.045,"week52Low":11.07,"pbRate":"--","week52High":12.5,"institutionHeld":0,"latestPrice":12.0818,"eps":1.02,"divideRate":0.070072,"volume":6203,"delay":0,"ttmEps":1.02,"open":12.0707,"prevYearClose":11.72,"prevWeekClose":12.1,"prevMonthClose":12.04,"prevQuarterClose":11.72,"fiveDayClose":12.024,"twentyDayClose":11.84,"sixtyDayClose":12.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMS\",params:#limit:5,,,undefined,":[{"date":"2026-02-13","symbol":"NMS","amount":0.0665,"announcedDate":"2026-02-02","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-13","defaultRemindTime":1770993000000,"name":"Nuveen Minnesota Municipal Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-02","payableDate":"2026-02-13","currency":"USD","dateTimestamp":1770958800000,"payDate":"2026-03-02"},{"date":"2026-01-15","symbol":"NMS","amount":0.0665,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-15","defaultRemindTime":1768487400000,"name":"Nuveen Minnesota Municipal Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-02","payableDate":"2026-01-15","currency":"USD","dateTimestamp":1768453200000,"payDate":"2026-02-02"},{"date":"2025-12-15","symbol":"NMS","amount":0.0665,"announcedDate":"2025-12-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-15","defaultRemindTime":1765809000000,"name":"Nuveen Minnesota Municipal Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-15","currency":"USD","dateTimestamp":1765774800000,"payDate":"2025-12-31"},{"date":"2025-11-14","symbol":"NMS","amount":0.0665,"announcedDate":"2025-11-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-14","defaultRemindTime":1763130600000,"name":"Nuveen Minnesota Municipal Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-01","payableDate":"2025-11-14","currency":"USD","dateTimestamp":1763096400000,"payDate":"2025-12-01"},{"date":"2025-10-15","symbol":"NMS","amount":0.0665,"announcedDate":"2025-10-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-15","defaultRemindTime":1760535000000,"name":"Nuveen Minnesota Municipal Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-03","payableDate":"2025-10-15","currency":"USD","dateTimestamp":1760500800000,"payDate":"2025-11-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMS\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-11","recordDate":"2016-03-15","paymentDate":"2016-04-01","value":0.0665,"currency":"USD"},{"executeDate":"2016-04-13","recordDate":"2016-04-15","paymentDate":"2016-05-02","value":0.0665,"currency":"USD"},{"executeDate":"2016-05-11","recordDate":"2016-05-13","paymentDate":"2016-06-01","value":0.0665,"currency":"USD"},{"executeDate":"2016-06-13","recordDate":"2016-06-15","paymentDate":"2016-07-01","value":0.0665,"currency":"USD"},{"executeDate":"2016-07-13","recordDate":"2016-07-15","paymentDate":"2016-08-01","value":0.0665,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610655881","title":"Blue Ocean Technologies Announces Executive Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2610655881","media":"prnewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610655881?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:30","pubTimestamp":1770643800,"startTime":"0","endTime":"0","summary":"Appoints Robert Virgilio as Chief Compliance Officer of Blue Ocean ATS & Expands South Korean Team with Addition of Daehyun Kim in new Trade Support Role. Virgilio holds a Bachelor of Science from Niagara University, an MBA from St. John's University, and FINRA Series 4, 7, 9/10, 14, 24, and 57 licenses. He is a past member of the SIFMA Self-Regulation and Supervisory Practices Committee, and NYSE Market Compliance Advisory Committee. Kim holds a Master of Commerce  from the University of Sydney and a Bachelor's/Diploma in Information Technology from Queensland University of Technology. He is a Certified Securities and Derivatives Investment Advisor (Korea Financial Inv","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/blue-ocean-technologies-announces-executive-changes-302681886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOT.AU","NMS","BK7096","BK4161","BK7508","BK7502","ATS"],"gpt_icon":0},{"id":"2607027511","title":"Nuveen Minnesota Quality Municipal Income Fund Announces Monthly Distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2607027511","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607027511?lang=en_us&edition=fundamental","pubTime":"2026-01-31 07:11","pubTimestamp":1769814665,"startTime":"0","endTime":"0","summary":"Nuveen Minnesota Quality Municipal Income Fund has issued a notice to shareholders regarding its monthly distribution as of December 31, 2025. The fund continues its policy of making regular monthly cash distributions and may include realized gains or a return of capital to maintain its declared per share distribution amount. No action is required from shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuveen Minnesota Quality Municipal Income Fund published the original content used to generate this news brief on January 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL7ZkJhd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMS"],"gpt_icon":0},{"id":"2600708457","title":"Nuveen Minnesota Quality Municipal Income Fund Issues Monthly Distribution Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2600708457","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600708457?lang=en_us&edition=fundamental","pubTime":"2026-01-01 00:15","pubTimestamp":1767197737,"startTime":"0","endTime":"0","summary":"Nuveen Minnesota Quality Municipal Income Fund has issued a notice to shareholders regarding its monthly distribution as of November 30, 2025. The fund aims to make regular monthly cash distributions and may distribute more or less than its net investment income in any period to maintain its declared distribution amount. No action is required from shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuveen Minnesota Quality Municipal Income Fund published the original content used to generate this news brief on December 31, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDLttpN9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMS"],"gpt_icon":0},{"id":"2592139106","title":"The National Museum of Singapore honours the nation's 60th anniversary with two new experiences to introduce Singapore's evolving story","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139106","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592139106?lang=en_us&edition=fundamental","pubTime":"2025-12-19 10:00","pubTimestamp":1766109600,"startTime":"0","endTime":"0","summary":"SINGAPORE, Dec. 19, 2025 /PRNewswire/ -- In celebration of Singapore's 60th anniversary of independence, the National Museum of Singapore  presents two commemorative experiences chronicling Singapore's transformation from settlement to global city and its major milestones over the past 700 years.(L-R) Once Upon a Tide: Singapore's Journey from Settlement to Global City and Singapore Odyssea: A Journey Through Time.Visitors can start their experience with Singapore Odyssea: A Journey Through Time at the Shaw Foundation Glass Rotunda, the first permanent gallery to reopen amid the museum's ongoing revamp. Intended as an introduction to Singapore's history, this immersive multimedia experience takes visitors back in time to witness formative moments in the nation's history. Through an RFID-enabled wristband, visitors can \"adopt\" one of nine Magical Companions inspired by Singapore's native fauna to guide them through the showcase and activate hidden layers of content on Singapore's histor","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2845697/Composite_images.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2845697/Composite_images.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/the-national-museum-of-singapore-honours-the-nations-60th-anniversary-with-two-new-experiences-to-introduce-singapores-evolving-story-302642538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMS","NHLD"],"gpt_icon":0},{"id":"2592911597","title":"Press Release: Evoke Pharma and QOL Medical Announce Expiration of Tender Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2592911597","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592911597?lang=en_us&edition=fundamental","pubTime":"2025-12-17 23:51","pubTimestamp":1765986660,"startTime":"0","endTime":"0","summary":"Evoke Stockholders Received $11.00 Per Share in Cash. SOLANA BEACH, Calif., and VERO BEACH, Fla., Dec. 17, 2025 /PRNewswire/. by QOL-EOS Merger Sub, Inc., a Delaware corporation and a direct wholly. owned subsidiary of QOL Medical , to acquire all of. the outstanding shares of common stock, par value $0.0001 per share (the. \"Shares\"), of Evoke, in exchange for $11.00 in cash per share (the. \"Offer Price\"), subject to any applicable withholding and without. interest thereon, expired at one minute past 11:59 p.m., New York City. Time, on December 15, 2025  and was not extended.Broadridge Corporate Issuer Solutions, LLC, the depositary for the Offer,has advised that, as of the Expiration Time, approximately 1,164,862. Shares were validly tendered and not validly withdrawn pursuant to the. Offer, representing approximately 67.63% of the issued and outstanding. Evoke , and all Shares that had not been validly tendered. in the Offer were canceled and converted into the right to receive the. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4207","BK4232","EVOK","BK4566","NMS","BK4007","TD","BK4585","R"],"gpt_icon":0},{"id":"2587732928","title":"Nuveen Minnesota Quality Municipal Income Fund Announces Monthly Distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2587732928","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587732928?lang=en_us&edition=fundamental","pubTime":"2025-11-29 03:53","pubTimestamp":1764359592,"startTime":"0","endTime":"0","summary":"Nuveen Minnesota Quality Municipal Income Fund has issued a notice to shareholders regarding its monthly distribution as of October 31, 2025. The fund aims to make regular monthly cash distributions and may include net investment income, realized capital gains, or a return of capital to maintain its declared distribution amount. No action is required from shareholders at this time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuveen Minnesota Quality Municipal Income Fund published the original content used to generate this news brief on November 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDLnlgCb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMS"],"gpt_icon":0},{"id":"2581837972","title":"AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living","url":"https://stock-news.laohu8.com/highlight/detail?id=2581837972","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581837972?lang=en_us&edition=fundamental","pubTime":"2025-11-08 07:00","pubTimestamp":1762556400,"startTime":"0","endTime":"0","summary":"In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their lives impacted by tardive dyskinesia (TD) while taking AUSTEDO or AUSTEDO ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3184014/0/en/AUSTEDO-deutetrabenazine-tablets-and-AUSTEDO-XR-deutetrabenazine-extended-release-tablets-Demonstrate-Positive-Real-world-Impact-with-Patients-Reporting-Improvement-in-Involuntary-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NMS","TD","BK4207","BK4566"],"gpt_icon":0},{"id":"2581700471","title":"Cboe’s exit shows Australia needs Regulation NMS","url":"https://stock-news.laohu8.com/highlight/detail?id=2581700471","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581700471?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:56","pubTimestamp":1762383390,"startTime":"0","endTime":"0","summary":"Cboe’s decision to sell its Australian exchange is a disappointing outcome for the local market and a moment for reflection.For many investors and ETF issuers, Cboe Australia represented competition, innovation, and a genuine effort to modernise Australia’s market structure.Over the past decade, Cboe had built goodwill within Australia’s institutional trading community. It invested heavily in technology and market integrity, introduced global best practices, and played a quiet but meaningful role in promoting the growth of ETFs and other exchange-traded products.For that reason, Cboe’s exit represents more than just a business decision; it’s a signal that something isn’t quite right with our market structure.The key difference between Australia and the United States lies in one simple rule: the “best price” requirement.For a new entrant like Cboe, that’s a formidable barrier. Even with excellent technology and a global reputation, the lack of a formal “best price” protection makes it","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/cboe-s-exit-shows-australia-needs-regulation-nms","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/cboe-s-exit-shows-australia-needs-regulation-nms","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["NMS","XKO.AU","BK4588","BK4585","XJO.AU","FDN","BK4550","XAO.AU"],"gpt_icon":0},{"id":"2580224887","title":"Nuveen Minnesota Quality Municipal Income Fund Files Initial Beneficial Ownership Statement for VP and Treasurer Robert Tanner Page","url":"https://stock-news.laohu8.com/highlight/detail?id=2580224887","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580224887?lang=en_us&edition=fundamental","pubTime":"2025-11-04 06:51","pubTimestamp":1762210274,"startTime":"0","endTime":"0","summary":"Nuveen Minnesota Quality Municipal Income Fund Files Initial Beneficial Ownership Statement for VP and Treasurer Robert Tanner Page. Nuveen Minnesota Quality Municipal Income Fund has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Robert Tanner Page as the beneficial owner, serving in the role of Vice President and Treasurer. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuveen Minnesota Quality Municipal Income Fund published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL2D9DX5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMS"],"gpt_icon":0},{"id":"2574046591","title":"FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2574046591","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574046591?lang=en_us&edition=fundamental","pubTime":"2025-10-11 03:00","pubTimestamp":1760122800,"startTime":"0","endTime":"0","summary":"FDA approves UZEDY (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/10/3165077/0/en/FDA-Approves-Expanded-Indication-for-UZEDY-risperidone-Extended-Release-Injectable-Suspension-as-a-Treatment-for-Adults-Living-with-Bipolar-I-Disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","NMS","MIDD","LU1721429402.USD","BK4161","LU1721429741.USD","LU2211817866.USD"],"gpt_icon":0},{"id":"2569242424","title":"Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2569242424","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569242424?lang=en_us&edition=fundamental","pubTime":"2025-09-21 10:16","pubTimestamp":1758420960,"startTime":"0","endTime":"0","summary":"Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR (deutetrabenazine) extended-release tabletsPatients reported high s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/21/3153529/0/en/Patients-Taking-AUSTEDO-XR-deutetrabenazine-extended-release-tablets-Reported-Symptom-Improvement-and-High-Satisfaction.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4207","TD","NMS","BK4566"],"gpt_icon":0},{"id":"2569424732","title":"New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed","url":"https://stock-news.laohu8.com/highlight/detail?id=2569424732","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569424732?lang=en_us&edition=fundamental","pubTime":"2025-09-21 10:15","pubTimestamp":1758420900,"startTime":"0","endTime":"0","summary":"Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/21/3153528/0/en/New-Long-term-Safety-Data-from-the-Completed-Phase-3-SOLARIS-Trial-Support-the-Potential-of-Olanzapine-LAI-TEV-749-as-the-First-Long-Acting-Olanzapine-Treatment-Option-for-Schizoph.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4546","BK4207","BK4161","NMS","PSP","TD","DM","BK4566"],"gpt_icon":0},{"id":"2566696038","title":"Gilat Satellite announces AI transformation of its NMS integrated MCP","url":"https://stock-news.laohu8.com/highlight/detail?id=2566696038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566696038?lang=en_us&edition=fundamental","pubTime":"2025-09-11 19:15","pubTimestamp":1757589353,"startTime":"0","endTime":"0","summary":"Gilat Satellite (GILT) Networks announced the AI transformation of its Network Management System, NMS, integrating Model Context Protocol, MCP. The...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilat-satellite-announces-ai-transformation-of-its-nms-integrated-mcp-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilat-satellite-announces-ai-transformation-of-its-nms-integrated-mcp-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMS","GILT","BK4020"],"gpt_icon":0},{"id":"2566967937","title":"Gilat Becomes First to Market with AI-Powered Network Management System","url":"https://stock-news.laohu8.com/highlight/detail?id=2566967937","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566967937?lang=en_us&edition=fundamental","pubTime":"2025-09-11 19:01","pubTimestamp":1757588460,"startTime":"0","endTime":"0","summary":"Gilat’s AI transformation, enabling smarter automation, greater efficiency, and next-generation innovation in satellite communicationsPETAH TIKVA, Israel, Sept.  11, 2025  (GLOBE NEWSWIRE) -- Gilat Sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/11/3148444/11105/en/Gilat-Becomes-First-to-Market-with-AI-Powered-Network-Management-System.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","LU1064131342.USD","BK4532","NOC","SDS","BK4020","NMS","BK4585","LU2264538146.SGD","BK4603","BK4187","GILT","LU1988902786.USD","BK4564","BK4588"],"gpt_icon":0},{"id":"2563907289","title":"Nuveen Minnesota Quality Municipal Income Fund Releases August 2025 Distribution Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2563907289","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563907289?lang=en_us&edition=fundamental","pubTime":"2025-08-30 04:51","pubTimestamp":1756500704,"startTime":"0","endTime":"0","summary":"Nuveen Minnesota Quality Municipal Income Fund has released its Municipal 19 Notice for August 2025, providing shareholders with critical information regarding the fund's monthly distributions. The notice, which is informational and requires no action from shareholders, details the fund's distribution policy and its intention to distribute all or substantially all net investment income annually through regular monthly distributions. The report, based on data as of July 31, 2025, highlights that the final determination for distributions will be made in early 2026 and reported on Form 1099-DIV. More information can be found on Nuveen's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuveen Minnesota Quality Municipal Income Fund ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDL4yh8qP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMS","NIM"],"gpt_icon":0},{"id":"2562738312","title":"Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship","url":"https://stock-news.laohu8.com/highlight/detail?id=2562738312","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562738312?lang=en_us&edition=fundamental","pubTime":"2025-08-26 19:00","pubTimestamp":1756206000,"startTime":"0","endTime":"0","summary":"Separately Secures Access to OneGI Through Brentwood Pharmacy Agreement Gimoti Specialty Pharmacy Network to Almost Double with Additional Relationships SOLANA BEACH, Calif. and CHICAGO, Aug.  26, 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/26/3139145/28255/en/Evoke-Pharma-and-EVERSANA-Expand-GIMOTI-Access-to-Gastro-Health-and-Other-Large-GI-Practices-through-Omnicell-Relationship.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","EVOK","NMS","BK4585","TD","OMCL","BK4207","BK4007","BK4566","BK4082"],"gpt_icon":0},{"id":"2561461424","title":"Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book","url":"https://stock-news.laohu8.com/highlight/detail?id=2561461424","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561461424?lang=en_us&edition=fundamental","pubTime":"2025-08-21 19:00","pubTimestamp":1755774000,"startTime":"0","endTime":"0","summary":"SOLANA BEACH, Calif., Aug.  21, 2025  (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/21/3137013/28255/en/Evoke-Pharma-Announces-Listing-of-New-GIMOTI-Patent-in-FDA-Orange-Book.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","BK4566","BK4585","BK4007","TD","EVOK","NMS"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}